Navigation Links
FDA Approves New Drug to Fight Advanced Prostate Cancer
Date:5/15/2013

WEDNESDAY, May 15 (HealthDay News) -- The U.S. Food and Drug Administration announced Wednesday that it has approved a drug to help men with advanced prostate cancer whose disease has spread to the bones.

The drug, Xofigo, is targeted to patients with late-stage, metastatic disease that has spread to the bones but not to other organs, the FDA said in a news release. It is meant for patients who have already undergone surgery and/or drug therapies such as hormone-based treatments.

The FDA said Xofigo, marketed by Wayne, N.J.-based Bayer Pharmaceuticals, was approved more than three months ahead of the original August 2013 deadline the agency had set for a complete review. Instead, the drug was reviewed under the agency's "priority" review program, designated for medicines that appear safe and effective in a context where no good alternative therapy exists.

"Xofigo binds with minerals in the bone to deliver radiation directly to bone tumors, limiting the damage to the surrounding normal tissues," Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research, explained in the news release.

In a clinical trial involving more than 800 men with symptomatic prostate cancer that was resistant to hormonal therapy and had spread to the bones, men on Xofigo survived a median of 14 months compared to a little over 11 months for men taking a placebo. Side effects from Xofigo included nausea, diarrhea, vomiting and swelling of the legs and feet. Low levels of red and white blood cells, as well as platelets, were also reported among some patients taking Xofigo, the FDA said.

Pazdur noted that "Xofigo is the second prostate cancer drug approved by the FDA in the past year that demonstrates an ability to extend the survival of men with metastatic prostate cancer." The other drug, Xtandi, was approved by the FDA last August for men with hormone treatmen
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. FDA Approves Morning-After Pill Without a Prescription
2. FDA Approves New “Gummy Bear” Breast Implants, But Albany Plastic Surgeon Urges Caution
3. FDA Approves 1st in New Class of Type 2 Diabetes Drugs
4. FDA Approves New Multiple Sclerosis Drug
5. FDA Approves Drug for Older Women Experiencing Painful Sex
6. FDA Approves Bionic Eye to Help Against Rare Vision Disorder
7. MSSD Approves of the Encinitas School District’s Holistic Education
8. FDA Approves 3 New Drugs for Type 2 Diabetes
9. FDA Approves 1st Skin Patch to Combat Migraines
10. Environmental Protection Agency Approves MOMS by OdorXit as a Disinfectant
11. FDA Approves New Type of Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves New Drug to Fight Advanced Prostate Cancer
(Date:8/27/2014)... For those who want to build ... products are very practical. Top10BestSEOHosting.com today announces that ... the best ASP.NET hosting suppliers of this year. ... top web hosting provider for a long time, ... today. Recently proclaimed one of the fastest growing ...
(Date:8/27/2014)... Arrow, OK (PRWEB) August 27, 2014 When ... their guests a comfortable bed to sleep without breaking the ... the market for a new foam mattress set for the ... to sleep on, Bedding Mart has it all during their ... stock up on some of the best mattresses for the ...
(Date:8/27/2014)... Charlotte, NC (PRWEB) August 27, 2014 Taking ... extremes, the Steele Creek YMCA will host its ... Race on Saturday, September 13 at YMCA Camp ... in three race divisions: adult, youth and teams. Within ... pushing themselves to their physical limit - for a worthy ...
(Date:8/27/2014)... Canada Goose Parkas from CanadaGooseJackor.nu are great. By ... With unique detailing such as buttons, leather trim and a ... in opulence. Recently, the company has unveiled its new range ... , True enough, the new assortment comes in various popular ... off) on all these brand new items. By launching the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 The New ... ) is holding free events about “ Sexuality & ... Liz Treston. These straightforward and entertaining discussions are for ... Bussani Mobility (501 Concord Avenue, Mamaroneck, NY) and October ... Avenue, Bethpage, NY). , The New York Mobility ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Releases the Best ASP.NET Hosting Suppliers of This Year: Hostgator, Arvixe and FatCow 2Health News:Bedding Mart, Top Mattress Store in Broken Arrow Oklahoma, Announces a Huge Labor Day Sale 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:CanadaGooseJackor.nu: 2014 Canada Goose Banff Parkas At Discounted Prices 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2
... fiber is perhaps the first thing that doctors and ... a condition characterized by enlargement of blood vessels, in ... bleeding and uneasiness. ,According to the American Society ... by a variety of factors, including pregnancy, chronic constipation ...
... U.S President Bill Clinton is on a different trip. Bill Clinton ... grew up on rich, fat laden diets that did not even ... serious health trouble, leading to a major bypass surgery. Now, with ... with a motive to make the future generation, a leaner lot! ...
... blue Smarties will no longer fascinate kids after maker ... from them//. Nestlé said that it was only reacting ... that the artificial color could harm children. ... coloring was the one, which was most likely to ...
... billion for providing a nutritious diet to undernourished women ... the previous year. ,The main beneficiary would ... who will get the supplementary nutritious diet from mother ... and child welfare department official. ,The state's ...
... diet not only makes you slim, it may help ... Leeuwenburgh and other scientists from the University of Florida's ... calories a day and moderately increased the animals' activity. ... their average and significantly overturned the negative effects of ...
... have near normal lung function and seem to perform ... cancer patients//. Similarly, male lung cancer patients were likely ... which is characterized by progressive deterioration in lung function. ... the CHEST journal, a publication of the American College ...
Cached Medicine News:Health News:Male Lung Cancer Patients Less Likely To Perform Well in Lung Function Tests 2
(Date:8/27/2014)... TWi Pharmaceuticals, Inc. (4180.TT) today announced that ... States Food and Drug Administration (FDA) on its ... 125mg/ml oral suspension, the generic equivalent to Par ... under Hatch Waxman rules, it will be entitled ... completed the pre-launch preparation of the generic drug.  ...
(Date:8/27/2014)... Columbia and MENLO PARK, Calif. ... Inc. , (OTCQB: DMPI), developer of advanced cancer ... at the 16th Annual Rodman & Renshaw Global Investment ... LLC. The presentation will take place Tuesday, September 9th at ... floor) at the New York Palace Hotel in ...
(Date:8/27/2014)... 27, 2014 Varian Medical Systems (NYSE: VAR) today broke ... Salt Lake City manufacturing facility and allow ... Utah to ultimately create 1,000 new full ... " Utah is home ... of whom can be credited with Varian,s success in the ...
Breaking Medicine Technology:TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4
... Nfocus Neuromedical, Inc., an innovative medical device company ... brain aneurysms, today announced that the company received U.S. ... Vessel Occlusion System (VOS).  The Acta VOS provides physicians ... an array of common and potentially serious vascular lesions. ...
... 11, 2011 Reportlinker.com announces that a new ... Novo Nordisk A/S: PharmaVitae Profile ... Introduction This analysis ... Nordisk in the prescription pharmaceutical sector. The profile ...
Cached Medicine Technology:Nfocus Neuromedical Announces FDA 510(k) Clearance for Next Generation Device to Treat Vascular Lesions 2Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: